pharmaspills

🚨 COVID-19 prevention just got a boost. The FDA has authorized Xocova, a tablet designed for people recently exposed to COVID-19. Clinical trial results showed it lowered the chances of developing symptoms by nearly 70%. A promising addition to the fight against the virus. 💊 #pharmaspills #medtwitter #COVID19 #FDA #HealthNews

@Ausbones The symptom described is a third-person auditory hallucination (running commentary), where voices comment on the patient’s actions despite no external speaker being present

A patient hears voices commenting on his actions even when no one is present. What psychopathological symptom is being described?

@ranigupta_20 Meat

Delete one food from earth.

Building from 0? Building from 100? Building from 1,000? Doesn't matter. Growth starts with showing up. Say hi. 👋

@not_dying Arranged marriage meetings often feel like job interviews where both candidates are secretly the recruiters 😅

Meeting a stranger can be fun. Meeting the same stranger for an arranged marriage is different. Suddenly, it's less about understanding each other and more aout judgement. Everyone tries to spot the flaws before the other one can spot theirs.

Absolutely agree! It’s promising biotech for cancer survivors who lose fertility after treatment. Still early days in preclinical stages, but the potential to restore natural hormone function and motherhood options safely is huge. Excited to follow the progress 🧬💙 What aspect excites you most?

@pharmaspills This is a good development honestly. We are waiting patiently to see how they roll that out to save lives

🚨 Scientists Just Created Artificial Ovaries—And It Could Change Thousands of Lives Forever 👀🧬 This sounds like science fiction, but it may soon give cancer survivors a second chance at motherhood 💙 #PharmaSpills #ScienceNews #MedicalInnovation #CancerResearch #Healthcare #Biotech #FutureTech #Medicine #HealthNews #WomenInHealth #medtwitter

@endless54719 @Lostin_Silencee

@Mekusblaaq @whoisbako Up 🙋🏻‍♀️

they said midnight twitter is peak. who's up rn? 👀

@Ausbones Prilocaine toxicity is treated with methylene blue, especially when it causes methemoglobinemia💉🩸

How do you treat prilocaine toxicity?

@narendramodi जन्म दिवस की हार्दिक शुभकामना 🤝

Best wishes to Uttar Pradesh Chief Minister, Yogi Adityanath Ji on his birthday. His work towards the state’s progress is noteworthy. He has always focused on improving the quality of life for people and ensuring all-round growth. Praying for his long and healthy life. @myogiadityanath

@SurajKu64859907 Om Namah Shivaya 🙏

Mujhe Bharam Tha Jo Hai Mera, Tha Nahin Kabhi Mera Arth Kya Nirarth Kya, Jo Bhi Hai Sabhi Tera Tere Saamne Hai Jhuka, Mere Sar Pe Haath Rakh Tera..🙏 🙇‍♂️ Namo Namo Ji Shankara, Bholenath Shankara❤️ Har Har Mahadev 🔱🌸

@its_vishuuu Good morning mutual 🤝🌞

Good morning everyone🌞 Have a good day❤️

@Ausbones Oxidative phosphorylation (ETC) 🧬⚡ The cell’s biggest ATP factory

Which biochemical pathway produces most ATP in aerobic cells?

@_Shivkivani It looks delicious 😋

Healthy , guilt free home made mango ice cream.. Who wanna join?

@Sammy02210 Congratulations 🥳

I just hit 1.1k followers ❤️🎉

A few minutes to pray before you start your day🙏🙏

@komal_uk01 Good morning

Good morning everyone🌞

@swamy95000 The biggest mistake is assuming lower demand means weaker demand. Sometimes it’s just demand waiting for a better moment

China Is Weaponizing the Timing of Oil Demand China is not draining its oil reserves because prices are high. Those reserves are for real emergencies: Taiwan, the South China Sea, maritime disruption, or war. China does not build strategic reserves only to waste them during ordinary price pressure. So when China slows imports and draws lightly from inventories, it should be read as positioning, not panic. China is not stepping away from the oil market permanently. It is delaying its demand. That timing is the whole strategy. If China buys aggressively now, prices rise, but the US and its allies still have enough strategic reserves to push back against the spike. US can release barrels, calm the market, and reduce the political damage. That does not benefit China. It creates pressure too early, while the other side still has buffers. China’s stronger move is to wait. By reducing imports now and using only a small portion of its own inventories, China avoids triggering the full price spike before the US-led system is vulnerable. Meanwhile, other importers continue consuming barrels. Western inventories decline. Strategic reserves get drawn. The market’s margin of safety keeps shrinking. That is the point. China is not simply trying to make everyone else empty their reserves. If that were the only goal, China could keep buying normally and let the market tighten naturally. Instead, China is tapping inventories now because it wants to delay its own demand and save the real buying pressure for later. The squeeze comes when the US has already used much of its SPR flexibility. At that point, China can return as an aggressive buyer, not just for current consumption, but to refill its own reserves. That is when Chinese demand becomes a weapon. The same buying that looks manageable today becomes explosive once global inventories are lower and the US has less ability to cap prices. US then faces a worse set of choices. - Release more reserves it may no longer have enough of. - Pressure allies to absorb higher prices. - Force Gulf producers to deliver barrels which may not be possible. - Escalate against Iran and risk a deeper energy shock. Or make concessions. That is the trap. China’s goal is not to empty its own reserves. It is to use a limited draw now so it can bid harder later, when others have already spent their buffers. Lower Chinese imports today are not necessarily bearish. They may be delayed demand. And delayed demand becomes far more dangerous when the market has already lost its cushion. China’s weapon is not only its oil reserves. It is the timing.